NovaQuest Capital Management Mergers and Acquisitions Summary

Private Equity Profile

In the last 3 years, NovaQuest Capital Management has acquired 5 companies. It has also invested in 1 other.

NovaQuest Capital Management’s most common sectors for investment are life science (58%) and information technology (29%). The Firm’s most common investment types include buyout (lbo, mbo, mbi) (58%) and secondary buyout (29%). In total, NovaQuest Capital Management has invested in 4 US states and 2 different countries.

In the last 3 years, NovaQuest Capital Management has exited 2 companies. The Firm’s most common exit type is buyout (lbo, mbo, mbi) (50%).

Join Mergr to view NovaQuest Capital Management’s full profile and discover more large private equity firms just like it.

M&A Summary

  • M&A Total Activity8
    • M&A Buy Activity6
    • M&A Sell Activity2
  • Total Sectors Invested 3
  • Total Countries Invested 2
  • M&A Buy/Sell Connections 1
  • M&A Advisors 1

NovaQuest Capital Management

4208 Six Forks Road Suite 920,
Raleigh, North Carolina 27609
United States
(919) 459-8620
www.novaquest.com
melinda.grill-feder@nqcapital.com

NovaQuest Capital Management is a private equity firm focused on acquiring and investing in growth-stage middle-market healthcare companies. Specific areas of interest include life science, medical technology, healthcare/facility services, and healthcare focused IT. The Firm targets profitable companies valued up to $500 million with $20 to $100 million of revenue. NovaQuest Capital Management was established in 2000 and is based in Raleigh, North Carolina.


Investment Criteria

Sectors of Interest: Healthcare Services, Information Technology, Life Science, Medical Products

Target Transaction Types: Buyout (LBO, MBO, MBI), Growth Capital

Geographic Preferences: East US, Midwest US, South US, West US, Canada

Transaction Criteria Min Max
Target Revenue 20 100
Target EBITDA - -
Investment Size - -
Enterprise Value - 500
values in millions of USD

M&A Summary

Buy vs Sell

Year ≤ '15 '16 '17 '18 '19 '20 T
Buy (1.0/yr) # 1 - - 4 - 1 6
Sell (0.4/yr) # - - - 1 - 1 2
  8

Most Recent M&A

Company Date Value Type
Mileutis Ltd. 2020-10-19 - Growth Capital
Ness Ziona, Israel · www.mileutis.com
Clinical Ink, Inc. 2020-08-04 - Secondary Buyout
Horsham, Pennsylvania · www.clinicalink.com
Catalyst Clinical Research LLC 2018-10-31 - Buyout (LBO, MBO, MBI)
Durham, North Carolina · www.catalystcr.com
California Cryobank LLC 2018-06-15 - Buyout (LBO, MBO, MBI)
Los Angeles, California · www.californiacryobank.com
Clinical Ink, Inc. 2018-05-14 - Buyout (LBO, MBO, MBI)
Horsham, Pennsylvania · www.clinicalink.com
Azurity Pharmaceuticals, Inc. 2018-03-26 - Secondary Buyout
Woburn, Massachusetts · www.cutispharma.com
Viamet Pharmaceuticals, Inc. 2018-01-03 - Buyout (LBO, MBO, MBI)
Durham, North Carolina · www.viamet.com
California Cryobank LLC 2014-08-20 - Buyout (LBO, MBO, MBI)
Los Angeles, California · www.californiacryobank.com
View All >>

Portfolio M&A

Company Acquired Add-On/Sale Date #
Azurity Pharmaceuticals, Inc. 2018-03-26 Silvergate Pharmaceuticals, Inc. 2019-06-12 1
Woburn, Massachusetts · www.cutispharma.com Greenwood Village, Colorado · www.silvergatepharma.com
Catalyst Clinical Research LLC 2018-10-31 Triangle Biostatistics LLC 2019-03-05 1
Durham, North Carolina · www.catalystcr.com Raleigh, North Carolina · www.trianglebiostatistics.com

M&A by Sector

Sector Current # Value All-time # Value
Life Science 3 (60%) - 4 (57%) -
Information Technology 1 (20%) - 2 (29%) -
Staffing 1 (20%) - 1 (14%) -
Total 5 - 7 -

Acquisitions By Geo

State/Country Current # Value All-time # Value
United States 4 (80%) - 6 (86%) -
  North Carolina 2 (40%) - 2 (29%) -
  Pennsylvania 1 (20%) - 2 (29%) -
  Massachusetts 1 (20%) - 1 (14%) -
  California - - 1 (14%) -
Israel 1 (20%) - 1 (14%) -
Total 5 - 7 -

Acquisitions by Deal Type

Type Current # Value All-time # Value
Buyout (LBO, MBO, MBI) 2 (40%) - 4 (57%) -
Secondary Buyout 2 (40%) - 2 (29%) -
Growth Capital 1 (20%) - 1 (14%) -
Total 5 - 7 -

Exits by Deal Type

Type Total # Value
Secondary Sale 2 (100%) -
Total 2 -

Top M&A Advisors

Legal Deals
Wyrick Robbins Yates & Ponton LLP
2

M&A Connections

Deals %
Acquired from
PE Firm(s)
50%
1 50%
Strategic(s)
50%
1 50%
Exited to
PE Firm(s)
100%
2 100%

 Subscribe to unlock this and 156,669
investor and company profiles

Sign-up today to get full access

  • check  Unlimited Searches
  • check  Unlimited Profile Views
  • check  Build and Export Lists of
    • PE Backed Companies
    • Direct Investors & Acquirers
    • Advisors
    • Deals
    • & More

What's Mergr?

We built Mergr to save people the arduous and time-consuming process of tracking when companies are bought, sold, and who currently owns them.

Every day, new opportunities emerge around M&A and we help professionals of all types comb through transactions, investors, and corporate acquirers via an easy-to-use web database that is accessible to anyone.

Try us for 1 week free today!

Mergr, the Easiest-to-Use PE and M&A DB


Key Benefits

  • Stay informed on events in your industry
  • M&A research that takes seconds (not all afternoon)
  • Better understand your customers and prospects
  • Discover active buyers (or sellers)
Search
  • 4.0K Private Equity Firms
  • 145K M&A Transactions
  • 153K Companies Involved in M&A
    (Buyer, Seller, or Target)
  • 3.1K M&A Advisors
    (Investment Banks and Law Firms)
  • 45K M&A Contacts
    (PE and M&A Advisors)

Ready to try?

Join FREE for 1 Week

No obligation. Cancel anytime.